According to FutureWise analysis, the Drug Discovery Services market in 2025 is US$21.4 billion and is expected to reach over US$68.22 billion by 2033 at a CAGR of 15.59%. The growth of the Drug Discovery Services market is driven by increased investments in research and development from pharmaceutical and biotechnology companies. A rising demand for targeted therapies and the integration of advanced technologies such as artificial intelligence, machine learning, and high-throughput screening further fuels this growth. In addition, more companies are outsourcing drug discovery activities to specialized service providers, which helps reduce costs and accelerate development timelines. The expansion is also supported by an increase in collaboration between contract research organizations (CROs) and pharmaceutical companies, along with growth in emerging markets. The demand for outsourcing early-stage drug development is on the rise, enhancing the rapid growth of the market. Drug discovery is the process of designing new medications. Common methods used in drug discovery include molecular manipulation, random screening, drug metabolite analysis, molecular design, and serendipity. Drug discovery services aim to minimize the costs and time involved in developing new drugs. This process is integral to pharmacology, biotechnology, and medicine, and typically involves several steps: identification, production, depiction, selection, and therapeutic assays. Once a compound proves effective in these assessments, it advances to drug development and clinical trials. Core activities within drug discovery services include drug target identification, selection of drug discovery candidates, fragment-based drug design, lead compound recognition, and lead optimization. Drug discovery services are also increasingly utilized in forensics, including paternity testing, disaster victim identification, and anthropology, where DNA analysis plays a crucial role.The market is experiencing rapid growth due to heightened R&D spending, a trend among major pharmaceutical companies to outsource in order to overcome obstacles, and a surge in demand for analytical testing and clinical trial services. Additionally, factors such as technological advancements, the adoption of innovative discovery methodologies, the rising demand for generic medications, and the expiration of patents are contributing to this global expansion. The overall growth of the healthcare sector, the increasing elderly population, and enhancements in drug discovery services also play significant roles in driving market demand.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Services Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=3465&type=requestsample

By Process

• Target Selection
• Target Validation
• Hit-to-Lead Identification
• Lead Optimization
• Candidate Validation

By Type

• Medicinal Chemistry
• Biology Services
• Drug Metabolism and Pharmacokinetics

By Drug Type

• Small Molecules
• Biologics

By Therapeutic Area

• Oncology
• Neurology
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes
• Other Therapeutics Areas

By Company Type

• Tier 1 Pharmaceutical Companies
• Tier 2 Pharmaceutical Companies
• Tier 3 Pharmaceutical Companies

• Wholesale

• • Retail (in-store)
  • Distributors/ Franchises

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Drug Discovery Services Market:

• Thermo Fisher Scientific
• Merck
• GE Healthcare
• Albany Molecular Research, Inc (AMRI)
• Charles River Laboratories International
• Evotec
• Pharmaceutical Product Development, LLC. (Ppd)
• Jubilant Biosys
• Covance
• Genscript Biotech Corporation
• Aurigene Discovery Technologies
• Wuxi Apptec
• Syngene
• Eurofins Scientific
• GVK Biosciences Private Limited
• Laboratory Corporation of America Holdings
• Lonza Group AG
• Piramal Enterprises Ltd
• Viva Biotech
• Dalton Pharma Services
• Domainex
• Selvita S.A.
• SRI International
• BioDuro

Recent developments by key players in the Drug Discovery Services Market:

Thermo Fisher Scientific

• Thermo Fisher continues to experience strong demand for its drug discovery tools and contract research organization (CRO) services, reporting second-quarter revenues of $10.85 billion. This performance exceeds estimates and indicates stability in biotechnology and pharmaceutical spending.
• Its subsidiary, PPD, Inc., is essential for service expansion, providing integrated drug development, laboratory services, and lifecycle management as part of Thermo Fisher’s broader strategy

Merck

• Merck is expanding its Exploratory Science Center in Cambridge, MA, by adding approximately 160,000 square feet. This expansion will accommodate up to 250 scientists who will focus on drug discovery and licensing initiatives driven by the microbiome and the immune system.
• In 2024, it completed several strategic acquisitions—including Abceutics ($208M), EyeBio ($3B), and Modifi Biosciences (~$1.3B)—which enhanced its pipeline and R&D capabilities.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=3465&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Drug Discovery Services Market By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com